Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Wissam Elfallal

Neurological Surgery Daytona Beach, FL Doctor of Osteopathy

NPI 1730594805 CMS profile 611970

305 Memorial Medical Pkwy Ste 505, Daytona Beach, FL 32117

Open in the dashboard

General payments

$7,444

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Wissam Elfallal of Daytona Beach, FL is reported in the CMS Open Payments database as having received $7,444 across 142 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $921 27
2024 General $1,203 25
2023 General $926 23
2022 General $1,976 37
2021 General $1,056 17
2019 General $1,362 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wissam Elfallal
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Wissam Elfallal were reported at $921. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Wissam Elfallal Neurological Surgery median Middle half National median
2019 $1,362 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $1,056 $387 $105–$2,432 $132
2022 $1,976 $542 $139–$2,989 $149
2023 $926 $534 $145–$2,697 $160
2024 $1,203 $574 $155–$3,046 $164
2025 $921 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,470 21 payments
  2. Medtronic, Inc. $1,246 15 payments
  3. Abbott Laboratories $931 17 payments
  4. Medtronic USA, Inc. $684 3 payments
  5. Orthofix Medical, Inc. $423 9 payments
  6. NuVasive, Inc. $259 1 payment
  7. RTI Surgical, Inc. $226 3 payments
  8. Boston Scientific Corporation $224 5 payments
  9. Saluda Medical Americas, Inc. $201 6 payments
  10. DePuy Synthes Sales Inc. $159 2 payments
  11. Other $1,620 60 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,225 134 payments
  2. Travel and Lodging $1,219 8 payments
Products named General payments · program years 2019–2025
  1. PIVOX Oblique Lateral Spinal System $773 6 payments
  2. CD HORIZON $684 3 payments
  3. SPINEJACK $512 5 payments
  4. PROCLAIM $341 7 payments
  5. INTELLIS ADAPTIVESTIM $310 4 payments
  6. UNIVERSAL NEURO 3 $284 5 payments
  7. NVM5 $259 1 payment
  8. NSE - HIGH SPEED DRILLS $218 5 payments
  9. Evoke $201 6 payments
  10. SIMMETRY IMPLANT, 12.5MM X 50MM $182 2 payments
  11. Other $4,277 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

217

Median for Neurosurgery: 83

Drug cost

$2,861

Median for Neurosurgery: $872

Branded share of claims

18.9%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lidocaine Generic 12 $1,176
Methylprednisolone Generic 90 $654
Cyclobenzaprine Hcl Generic 58 $416
Gabapentin Generic 16 $311
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $190
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $113

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$188,005

Medicare's payments for the services billed

Medicare patients

368

Average age 75

Services billed

984

199 women, 169 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 42%
Chronic kidney disease 41%
Diabetes 37%
Depression 33%
COPD 30%
Osteoporosis 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record